Comparative effectiveness of turmeric and curcumin formulations on glycemic, lipid, and inflammatory markers in people with prediabetes: a systematic review and network meta-analysis
Complementary Therapies in Medicine · 2026-12 · 103 · 103453
DOI: 10.1016/j.ctim.2026.103453 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Complementary Therapies in Medicine, 2026-12. Verfasst von Phatcharaporn Khongphakdee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Technology, Faculty of Agro-Industry, Kasetsart University, Bangkok, 10900, Thailand; Department of Nutrition, Thasala…. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Higher Education Science Research and Innovation.
Abstract (Originalsprache)
Prediabetes is a growing global health concern associated with higher risk of diabetes and cardiovascular disease. Curcumin has been studied for glycemic, lipid, and inflammatory effects, but comparative data across formulations remain limited. This network meta-analysis (NMA) evaluated turmeric and curcumin formulations in adults with prediabetes. Seven databases were searched for randomized controlled trials (RCTs) comparing turmeric/curcumin formulations with placebo. Primary outcomes included glycemic, lipid, and inflammatory markers. Two reviewers independently extracted data and assessed risk of bias. NMAs with surface under the cumulative ranking curve (SUCRA) were performed. Twenty-four RCTs (25 publications, 1952 participants; mean baseline fasting blood sugar (FBS): 110.3 mg/dL) evaluating eight curcumin-based formulations were included. Turmeric extract combined with other compounds (EC) and turmeric extract (E) were associated with significant reductions in FBS with WMD -10.73 (95%CI: -14.22, -7.25;SUCRA 92.2%), and -10.57 (95%CI: -14.35, -6.79;91.5%;SUCRA 91.5%), respectively. E was associated with a significant reduction in HbA1c, while EC was associated with lower HOMA-IR with MWD -0.73 (95%CI: -1.41, -0.05; SUCRA 79.8%). Whole turmeric with other compounds (WC) was associated with a significant reduction in LDL-C (WMD: -37.19, 95%CI: -56.97, -17.42; SUCRA: 97.3%). E was associated with a lower risk of incident type 2 diabetes (RR= 0.05; 95%CI:0.00,0.78), although this estimate was based on low-certainty of evidence. No significant effects were observed for inflammatory markers. Overall certainty of evidence was low due to heterogeneity and short trial durations, and variability among combination formulations. In prediabetes, formulation-specific metabolic effects were observed. However, given the low certainty of evidence, these findings should be interpreted cautiously and confirmed in larger, longer-term trials before clinical recommendation can be made.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Food Science and Technology, Faculty of Agro-Industry, Kasetsart University, Bangkok, 10900, Thailand; Department of Nutrition, Thasala Hospital, Nakhon Si Thammarat, 80160, Thailand.
- Department of Food Science and Technology, Faculty of Agro-Industry, Kasetsart University, Bangkok, 10900, Thailand.
- Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hatyai, Songkhla, 90110, Thailand; Advancing Collaboration, Translation, and Innovation for Value…
- Advancing Collaboration, Translation, and Innovation for Value in Evidence Synthesis (ACTIVES) Hub of Talent, Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand; Clinical Trials and Evidence-…
- Department of Food Science and Technology, Faculty of Agro-Industry, Kasetsart University, Bangkok, 10900, Thailand. Electronic address: fagists@ku.ac.th.
Förderung
- Ministry of Higher Education Science Research and Innovation
Zitieren
APA
Khongphakdee, P., Jumnianpol, J., Puttarak, P., Sawangjit, R., & Sae-Tan, S. (2026). Comparative effectiveness of turmeric and curcumin formulations on glycemic, lipid, and inflammatory markers in people with prediabetes: a systematic review and network meta-analysis. Complementary Therapies in Medicine, 103, 103453. https://doi.org/10.1016/j.ctim.2026.103453
Vancouver
Khongphakdee P, Jumnianpol J, Puttarak P, Sawangjit R, Sae-Tan S. Comparative effectiveness of turmeric and curcumin formulations on glycemic, lipid, and inflammatory markers in people with prediabetes: a systematic review and network meta-analysis. Complementary Therapies in Medicine. 2026;103:103453. doi:10.1016/j.ctim.2026.103453
BibTeX
@article{Khongphakdee2026,
author = {Khongphakdee, Phatcharaporn and Jumnianpol, Jaruwan and Puttarak, Panupong and Sawangjit, Ratree and Sae-Tan, Sudathip},
title = {Comparative effectiveness of turmeric and curcumin formulations on glycemic, lipid, and inflammatory markers in people with prediabetes: a systematic review and network meta-analysis},
journal = {Complementary Therapies in Medicine},
year = {2026},
volume = {103},
pages = {103453},
doi = {10.1016/j.ctim.2026.103453}
}
EUVIMED